Valproic acid, valproate and divalproex in maintenance treatment of bipolar disorder
This is a review done by the Cochrane Collaboration, a group I would NOT want to argue with about their conclusions. Basically, the new “major psychoactive drug of the week” has very little evidence behind its increasing use. But hey, just because it is not as effective and costs multiples more with much more severe side effects (you know…weight gain, death from liver failure…) does not mean we shouldn’t use it…
Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder (Cochrane Review)